Andreas Ranft

Risk of recurrence and survival after relapse in patients with Ewing sarcoma

Martin Stahl, Andreas Ranft, Michael Paulussen et al. · Pediatric Blood & Cancer · 2011 · 321 citations

Medicine, Oncology, Surgical Oncology +12

Impact of <i>EWS-ETS</i> Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial

Marie‐Cécile Le Deley, Olivier Delattre, Karl‐Ludwig Schaefer et al. · Journal of Clinical Oncology · 2010 · 202 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial

Marie‐Cécile Le Deley, Michael Paulussen, Ian Lewis et al. · Journal of Clinical Oncology · 2014 · 173 citations · Full text

Medicine, Oncology, Pharmacology +16

Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors

Andrea Hunold, Nicole Weddeling, Michael Paulussen et al. · Pediatric Blood & Cancer · 2006 · 169 citations

Medicine, Oncology, Pharmacotherapy +15

The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)

Julia Haeusler, Andreas Ranft, T. Boelling et al. · Cancer · 2009 · 169 citations · Full text

Medicine, Oncology, Surgery +10